One Year Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Pediatric Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study
Phase of Trial: Phase III
Latest Information Update: 04 Feb 2019
At a glance
- Drugs Dupilumab (Primary)
- Indications Asthma
- Focus Adverse reactions; Registrational
- Acronyms Liberty Asthma Excursion
- Sponsors Sanofi
- 29 Aug 2018 Planned number of patients changed from 236 to 377.
- 06 Jun 2018 Status has been changed to recruiting.
- 08 May 2018 New trial record